Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.06.2018 | Case report

Lapatinib/osimertinib

Oral mucositis/stomatitis: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Yurikusa T, et al. Distinguishing epithelial growth factor receptor tyrosine kinase inhibitor induced or almucositis / stomatitis from pseudomembranous candidiasis: Case series. Supportive Care in Cancer 26 (Suppl. 2): S154-S155 abstr. eP207, No. 2, Jan 2018. Available from: URL: http://doi.org/10.1007/s00520-018-4193-2 Yurikusa T, et al. Distinguishing epithelial growth factor receptor tyrosine kinase inhibitor induced or almucositis / stomatitis from pseudomembranous candidiasis: Case series. Supportive Care in Cancer 26 (Suppl. 2): S154-S155 abstr. eP207, No. 2, Jan 2018. Available from: URL: http://​doi.​org/​10.​1007/​s00520-018-4193-2
Metadaten
Titel
Lapatinib/osimertinib
Oral mucositis/stomatitis: 2 case reports
Publikationsdatum
01.06.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-47627-7

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Tenofovir

Case report

Oxybutynin

Case report

Adalimumab

Case report

Carbamazepine